Cansino Biologics Inc. Posted 1.3 Billion Yuan Net Loss in First Half of 2023

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net loss of 1.3 billion yuan in the first half of 2023, reversing a net profit of 16 million yuan for the same period in the previous year.

Meanwhile, the company posted 25.9 million yuan in revenue, down 95.9% year-on-year.

At the end of the reporting period, it had 9.9 billion yuan in total assets and 3.9 billion yuan in total liabilities, with a liability-to-asset ratio of 39.7%.